Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded
- Contract number
- SPE2DB25FN4NE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,362
Award facts
- Contract value 100% obligated
- $10,361.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with a contract ceiling value of $10,361.60. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive bidding with no set-aside designation. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves as a primary supplier to military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies. The company's pharmaceutical support under the DLA Medical Supply Chain encompasses a wide spectrum of therapeutic domains, including specialty medications and diabetes treatments such as the Ozempic being procured under this delivery order. The DLA Troop Support Medical contract enables comprehensive global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning AmerisourceBergen as a key partner in federal medical procurement.
Quick answers
Who was awarded contract SPE2DB25FN4NE?
SPE2DB25FN4NE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FN4NE worth?
The government has obligated $10,362 on SPE2DB25FN4NE.
Is contract SPE2DB25FN4NE an order under another contract?
Yes. SPE2DB25FN4NE is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN4NE competed?
The extent of competition for SPE2DB25FN4NE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award